Clinical Trials Logo

Clinical Trial Summary

The SONOCLOT Analyzer (S1; Sienco, Inc. Boulder, CO USA, Model DP-2951) is used to perform kaolin-based activated clotting time as routine monitor of heparin therapy in patients undergoing cardiac operations. In addition, the device allows the assessment of the patient's coagulation status by a glass-bead activated test. Recently, a new SONOCLOT analyzer (S2) has been developed. As part of the routine management using S1, tests are also performed on S2. Results are entered into the cardiac surgery data base of all cardiac surgery patients and analyzed.


Clinical Trial Description

The SONOCLOT Analyzer (S1; Sienco, Inc. Boulder, CO USA, Model DP-2951) is used to routinely perform kaolin-based activated clotting time (kACT) as monitor of heparin therapy in patients undergoing cardiac operations on cardiopulmonary bypass.

Apart from kACT, the device allows the assessment of the patient's coagulation status by a glass-bead activated test (gbACT+, depicting also clot rate = CR and platelet function = PF). Recently, a new SONOCLOT analyzer (S2) has been developed. Although the S2 shares the technical fundamentals with the S1, the redesign of the device may result in performance changes of kACT and gbACT.

Routine management in cardiac surgery patients is guided using S1 and addition, tests are run on S2. Data are entered into the the cardiac surgery data base and S1 and S2 performance is compared by Bland-Altman analysis and % error calculation in order to establish new reference values. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02588976
Study type Interventional
Source Triemli Hospital
Contact
Status Completed
Phase N/A
Start date July 2009
Completion date January 2011

See also
  Status Clinical Trial Phase
Completed NCT03572322 - Genetics Tests : How to Improve Management Within Two Medical Specialities
Recruiting NCT04125667 - Culture System for Isolating Circulating Tumor cells_2
Recruiting NCT05610098 - Gene Expression Profiles in Spinal Tuberculosis.
Completed NCT04507724 - The Use of Biochemical Analyzes to Monitor the Development of Wounds
Completed NCT02341677 - SmartTarget: BIOPSY N/A
Completed NCT03125629 - Comparison of PET/CT vs. PET/MRI Using 2 Radiopharmaceuticals Phase 2
Completed NCT02978131 - Histopathological Techniques and PCR on Tissues Included in Paraffin for the Diagnosis of Tuberculosis
Recruiting NCT01524276 - Product Surveillance Registry